These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 1417380

  • 1. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation.
    Prochazka AV, Petty TL, Nett L, Silvers GW, Sachs DP, Rennard SI, Daughton DM, Grimm RH, Heim C.
    Arch Intern Med; 1992 Oct; 152(10):2065-9. PubMed ID: 1417380
    [Abstract] [Full Text] [Related]

  • 2. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
    Ornish SA, Zisook S, McAdams LA.
    Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV, Kick S, Steinbrunn C, Miyoshi T, Fryer GE.
    Arch Intern Med; 2004 Nov 08; 164(20):2229-33. PubMed ID: 15534159
    [Abstract] [Full Text] [Related]

  • 4. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
    Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, De Blasio F.
    Arch Monaldi Mal Torace; 1992 Nov 08; 47(1-6):17-29. PubMed ID: 1306633
    [Abstract] [Full Text] [Related]

  • 5. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug 08; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 6. [Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].
    Cervantes Escárcega JL, Guadalajara Boo JF.
    Arch Inst Cardiol Mex; 1992 Aug 08; 62(5):435-40. PubMed ID: 1482222
    [Abstract] [Full Text] [Related]

  • 7. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
    Addiction; 2004 May 08; 99(5):634-40. PubMed ID: 15078238
    [Abstract] [Full Text] [Related]

  • 8. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG, Gitchell JG, Shiffman S, Sembower MA.
    Clin Ther; 2009 Sep 08; 31(9):1957-65. PubMed ID: 19843485
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR.
    Pediatrics; 2005 Apr 08; 115(4):e407-14. PubMed ID: 15805342
    [Abstract] [Full Text] [Related]

  • 10. Nicotine patch therapy in adolescent smokers.
    Smith TA, House RF, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.
    Pediatrics; 1996 Oct 08; 98(4 Pt 1):659-67. PubMed ID: 8885942
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
    Sachs DP, Säwe U, Leischow SJ.
    Arch Intern Med; 1993 Aug 23; 153(16):1881-90. PubMed ID: 8110249
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of buspirone in smoking cessation: a placebo-controlled trial.
    Schneider NG, Olmstead RE, Steinberg C, Sloan K, Daims RM, Brown HV.
    Clin Pharmacol Ther; 1996 Nov 23; 60(5):568-75. PubMed ID: 8941030
    [Abstract] [Full Text] [Related]

  • 13. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
    Arch Intern Med; 1994 May 09; 154(9):989-95. PubMed ID: 8179456
    [Abstract] [Full Text] [Related]

  • 14. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L, Busto UE, MacDonald A, Corrigall WA.
    Can J Clin Pharmacol; 2002 May 09; 9(4):175-82. PubMed ID: 12584575
    [Abstract] [Full Text] [Related]

  • 15. Clonidine for smoking cessation.
    Nana A, Praditsuwan R.
    J Med Assoc Thai; 1998 Feb 09; 81(2):87-93. PubMed ID: 9529836
    [Abstract] [Full Text] [Related]

  • 16. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
    Westman EC, Levin ED, Rose JE.
    Arch Intern Med; 1993 Aug 23; 153(16):1917-23. PubMed ID: 8250653
    [Abstract] [Full Text] [Related]

  • 17. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A.
    Psychopharmacology (Berl); 2002 Nov 23; 164(2):177-87. PubMed ID: 12404080
    [Abstract] [Full Text] [Related]

  • 18. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
    Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G.
    Prev Med; 1995 Jan 23; 24(1):41-7. PubMed ID: 7740014
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.
    Arch Intern Med; 2006 Mar 27; 166(6):667-74. PubMed ID: 16567607
    [Abstract] [Full Text] [Related]

  • 20. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL, Jones L, Lancaster T, Fowler GH.
    Br J Gen Pract; 1996 Mar 27; 46(404):145-8. PubMed ID: 8731618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.